Assessment of the Expectations and Fears of Pregnant Patients Monitored at the CMCO Regarding Ambulatory Epidural Anesthesia (Déambu-Péri)

January 7, 2026 updated by: University Hospital, Strasbourg, France

Ambulatory epidural anesthesia is a technique that has been described since the late 1990s and has been rapidly gaining popularity in recent years.

Although there is currently no change in the obstetric process, this technique has been shown to improve maternal satisfaction.

Ambulatory epidural s are not yet offered in the maternity wards of Strasbourg University Hospitals.

However, a protocol is currently being studied and should be rolled out soon at the maternity ward of the Centre Médico-chirurgical Obstétrique (CMCO).

This study aims to assess the general interest in this technique among the population concerned.

It also seeks to highlight any fears patients may have that could hinder the implementation of the protocol.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • France
      • Strasbourg, France, 67091
        • Recruiting
        • Service d'Anesthésie Réanimation médecine Péri-Opératoire - CHU de Strasbourg - France
        • Contact:
        • Principal Investigator:
          • Stéphanie KOESSLER, MD
        • Sub-Investigator:
          • Giulia BENNATI, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

- Adult pregnant women monitored at the CMCO

Description

Inclusion Criteria:

  • Adult women (≥18 years old)
  • Pregnant women monitored at the CMCO

Exclusion Criteria:

  • Refusal to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Percentage of patients who expressed interest in ambulatory epidural anesthesia
Time Frame: Up to 12 months
Up to 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Strasbourg, France

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 5, 2025

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

November 5, 2026

Study Registration Dates

First Submitted

January 7, 2026

First Submitted That Met QC Criteria

January 7, 2026

First Posted (Estimated)

January 16, 2026

Study Record Updates

Last Update Posted (Estimated)

January 16, 2026

Last Update Submitted That Met QC Criteria

January 7, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 9946

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ambulatory Epidural

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe